We analyzed the levels of cyclin E (as a marker of cell proliferation) and of CRIPTO in tumor xenografts harvested at different times of treatment, i.e. after the first week of treatment, at treatment stop and after three additional weeks of tumor growth. This evidence concerns the gene CCNE1 and neoplasm.